225 related articles for article (PubMed ID: 33155888)
1. Development and Validation of a LC-MS/MS Method for Quantification of Mobocertinib (TAK-788) in Plasma and its Application to Pharmacokinetic Study in Rats.
Li B; Wang J; Dou X; Zhang X; Xue X; Xu Q; Ran W; Xiong S
Comb Chem High Throughput Screen; 2021; 24(9):1410-1416. PubMed ID: 33155888
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Study of Hypaphorine, a Potential Agent for Treating Osteoclast-based Bone Loss, on Rats Using LC-MS/MS.
Zhang T; Yan Y; Xue Y; Xiong S; Ran W; Xu Q
Comb Chem High Throughput Screen; 2022; 25(11):1889-1896. PubMed ID: 34610780
[TBL] [Abstract][Full Text] [Related]
5. A selective and robust UPLC-MS/MS method for the simultaneous quantitative determination of anlotinib, ceritinib and ibrutinib in rat plasma and its application to a pharmacokinetic study.
Du P; Guan Y; An Z; Li P; Liu L
Analyst; 2019 Sep; 144(18):5462-5471. PubMed ID: 31380858
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of alflutinib and its active metabolite in human plasma using liquid chromatography-tandem mass spectrometry.
Liu X; Li W; Zhang Y; Jiang Y; Zhao Q; Zhong D
J Pharm Biomed Anal; 2019 Nov; 176():112735. PubMed ID: 31394305
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Determination of AZD3264, a Selective Ikb-Kinase IKK2 Inhibitor, in Dog Plasma by Solvent-Induced Phase Transition Extraction Coupled with HPLC-MS/MS and its Application to Pharmacokinetic Study in Dogs.
Li G; Liang S; Qiao K; Wang C
J AOAC Int; 2021 May; 104(2):348-354. PubMed ID: 33259588
[TBL] [Abstract][Full Text] [Related]
8. A rapid and sensitive LC-MS/MS method for evaluation of the absolute oral bioavailability of a novel c-Met tyrosine kinase inhibitor QBH-196 in rats.
Zhang Q; Sun J; Lu T; Zhang J; Wu C; Li L; He Z; Zhao Y; Liu X
Biomed Chromatogr; 2015 Nov; 29(11):1650-6. PubMed ID: 25880630
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of sacubitrilat and fimasartan in rat plasma by a triple quad liquid chromatography-tandem mass spectrometry method utilizing electrospray ionization in positive mode.
Giri P; Joshi V; Giri S; Delvadia P; Jain MR
Biomed Chromatogr; 2021 Feb; 35(2):e4981. PubMed ID: 32895916
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
Maher HM; Alzoman NZ; Shehata SM
J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
[TBL] [Abstract][Full Text] [Related]
12. A simple LC-MS/MS method for simultaneous determination of cilostazol and ambroxol in Sprague-Dawley rat plasma and its application to drug-drug pharmacokinetic interaction study following oral delivery in rats.
Zhou H; Zhang M; Sun L; Li W; Liu Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122766. PubMed ID: 34247102
[TBL] [Abstract][Full Text] [Related]
13. A rapid UHPLC-MS/MS method for the quantification of ARQ531 in rat plasma: Validation and its application to a pharmacokinetic study.
Liu J; Ji M; Li Z; Xu X; Li L; Li H; Tian Y; Su X
Biomed Chromatogr; 2020 Nov; 34(11):e4937. PubMed ID: 32614971
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.
Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Khagga M
Arzneimittelforschung; 2012 Dec; 62(12):624-30. PubMed ID: 23138519
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
[TBL] [Abstract][Full Text] [Related]
16. Development of UHPLC-MS/MS Method for Indirubin-3'-Oxime Derivative as a Novel FLT3 Inhibitor and Pharmacokinetic Study in Rats.
Kim NY; Kim YC; Kim YG
Molecules; 2020 Apr; 25(9):. PubMed ID: 32349415
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of calycosin-7-O-β-D-glucoside, cinnamic acid, paeoniflorin and albiflorin in rat plasma by UHPLC-MS/MS and its application to a pharmacokinetic study of Huangqi Guizhi Wuwu Decoction.
Guan J; Wang L; Jin J; Chang S; Xiao X; Feng B; Zhu H
J Pharm Biomed Anal; 2019 Jun; 170():1-7. PubMed ID: 30897430
[TBL] [Abstract][Full Text] [Related]
18. A novel LC-MS/MS method for the determination of ziritaxestat in rat plasma and its pharmacokinetic study.
Chen J; Guan Z; Dong N; Li X
Biomed Chromatogr; 2020 Aug; 34(8):e4863. PubMed ID: 32329073
[TBL] [Abstract][Full Text] [Related]
19. Determination of selpercatinib, a RET kinase inhibitor, in rat plasma and its application to a pharmacokinetic study.
Wang W; Shi L; Jin L; Wang K
Biomed Chromatogr; 2021 May; 35(5):e5052. PubMed ID: 33314236
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
Reis R; Labat L; Allard M; Boudou-Rouquette P; Chapron J; Bellesoeur A; Thomas-Schoemann A; Arrondeau J; Giraud F; Alexandre J; Vidal M; Goldwasser F; Blanchet B
J Pharm Biomed Anal; 2018 Sep; 158():174-183. PubMed ID: 29883880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
